KATHERINE SCHMIDT: Open Payments
NPI 1457440802 · WALNUT HILLS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 26 payments from 10 companies in 2025. Trend: 2023 $773 · 2024 $687 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $286 |
| Teva Pharmaceuticals USA, Inc. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| ABBVIE INC. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $19 |
| Braeburn Inc. | 1 | $15 |
| Indivior Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA, VRAYLAR, UZEDY, HETLIOZ, ARISTADA, Secuado.
Industry payments across OH — which companies pay providers there.
